Chondroitin sulfate - Novartis
Alternative Names: Chondroitin 6-sulfate sodium - Alcon; Chondroitin 6-sulfate sodium - Nestle; Chondroitin sulfate - Nestle; Chondroitin sulphate - Alcon; Chondroitin sulphate - Nestle; LacryposLatest Information Update: 24 Sep 2021
At a glance
- Originator Alcon
- Developer Novartis
- Class Anti-inflammatories; Antirheumatics; Glycosaminoglycans
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Dry eyes; Eye disorders
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
- 26 Aug 2010 Alcon has been acquired by Novartis
- 22 Jan 1999 New profile